文献速递青光眼

Paul青光眼引流器腔内支架取出术后眼压变化:系统综述与荟萃分析

Intraocular Pressure Changes Following Intraluminal Stent Removal From the Paul Glaucoma Implant: A Systematic Review and Meta-Analysis.
PubMed 文献 · Am J Ophthalmol · 2026-06-06

该系统综述与单臂荟萃分析纳入5项观察性研究共283眼,评估Paul青光眼引流器(PGI)腔内支架取出对眼压的影响。结果显示支架取出后眼压显著即刻下降,合并均差为-9.09 mmHg(95%CI -11.77至-6.41),术前高眼压亚组下降更明显。临床低眼压发生率低且一致性高。

要点

  • PGI腔内支架取出后眼压显著即刻下降,合并均差-9.09 mmHg。
  • 术前眼压>21 mmHg亚组眼压下降-11.82 mmHg,优于低眼压亚组。
  • 临床低眼压 pooled 比例仅0.03,安全性良好。

核心结论

  • PGI腔内支架取出是有效且安全的降眼压干预措施。
  • 术前高眼压患者支架取出后眼压下降更显著。

研究设计与样本

  • 系统综述与单臂荟萃分析,检索EMBASE、Medline和CENTRAL。
  • 最终纳入5项观察性研究,共283眼。
  • 采用ROBINS-I工具评估偏倚风险,连续变量用均差(MD)及95%CI分析。
  • 二分类变量用合并比例及95%CI评估,均采用随机效应模型。

主要发现

  • 支架取出后眼压即刻下降显著,合并MD为-9.09 mmHg(95%CI -11.77至-6.41)。
  • 术前高眼压(>21 mmHg)亚组眼压下降-11.82 mmHg(95%CI -10.14至-13.51)。
  • 术前低眼压(<21 mmHg)亚组眼压下降-6.66 mmHg(95%CI -5.55至-7.77)。
  • 临床低眼压合并比例为0.03(95%CI 0.00至0.15),异质性I²=0.00%。

关键数值与推荐

  • 术前高眼压定义为>21 mmHg,低眼压定义为<21 mmHg。
  • 眼压下降计算为支架取出后即刻眼压减去取出前眼压。

临床怎么用

  • PGI植入后持续高眼压患者可考虑取出腔内支架以降低眼压。
  • 术前高眼压患者支架取出降眼压效果更明显。

局限性

  • 仅纳入5项观察性研究,证据等级受限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: This study aims to systematically review and perform a single-arm meta-analysis to comprehensively evaluate the effect of removal of intraluminal stent from the Paul glaucoma implant (PGI) on intraocular pressure (IOP) changes and to summarize its long-term efficacy and safety. CLINICAL RELEVANCE: Glaucoma remains one of the leading global causes of irreversible vision loss, necessitating effective surgical management for refractory cases. Glaucoma drainage devices are critical for these complex forms, and intraluminal stent removal from the PGI serves as a key strategy to titrate aqueous outflow and optimize long-term IOP control. METHODS: A systematic review was conducted by searching EMBASE, Medline, and CENTRAL. The meta-analysis ultimately included 5 observational studies. The Risk of Bias in Nonrandomized Studies of Interventions (ROBINS-I) tool was used to assess the quality of the included studies. Continuous outcomes (eg, postremoval stent IOP reduction) were analyzed using the mean difference (MD) with 95% confidence intervals (CI); dichotomous outcomes (eg, hypotony incidence) were evaluated using pooled proportion with 95% CI. All meta-analyses employed a random-effects model. RESULTS: Our meta-analysis included 5 studies, involving a total of 283 eyes. The meta-analysis revealed that removal of the stent leads to a significant and immediate IOP reduction. The IOP reduction (immediate postremoval stent IOP minus preremoval stent IOP) was significant, with a pooled MD of -9.09 mm Hg IOP (MD = 9.09; 95% CI = [-11.77, -6.41]). In the preremoval stent high-IOP (>21 mm Hg) subgroup, the IOP reduction is -11.82 (95% CI = [-10.14, -13.51]). This reduction was significantly greater than the preremoval stent low-IOP (<21 mm Hg) subgroup, whose reduction is -6.66 mm Hg (95% CI = [-5.55, -7.77]). Regarding safety, the pooled proportion of clinically hypotony was low and highly consistent (I² = 0.00%) at only 0.03 (95% CI = [0.00, 0.15]). CONCLUSIONS: Intraluminal stent removal from the PGI is an effective and safe IOP-lowering intervention. Its IOP reduction effect is significantly more pronounced in patients with preremoval stent high IOP, providing crucial clinical guidance for managing persistently high IOP after PGI implantation.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Lan CH, Pao SI, Tseng HL, et al. Intraocular Pressure Changes Following Intraluminal Stent Removal From the Paul Glaucoma Implant: A Systematic Review and Meta-Analysis. Am J Ophthalmol. 2026. PMID: 42250672. doi:10.1016/j.ajo.2026.05.047

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。